Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for Beauty Health (SKIN) over the last 6 years, with Q3 2025 value amounting to $1.1 million.

  • Beauty Health's Amortization of Deferred Charges fell 2482.66% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 491.09%. This contributed to the annual value of $4.2 million for FY2024, which is 61.48% down from last year.
  • Beauty Health's Amortization of Deferred Charges amounted to $1.1 million in Q3 2025, which was down 2482.66% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Beauty Health's Amortization of Deferred Charges ranged from a high of $3.8 million in Q2 2022 and a low of -$9.2 million during Q4 2021
  • Its 5-year average for Amortization of Deferred Charges is $1.1 million, with a median of $1.1 million in 2023.
  • As far as peak fluctuations go, Beauty Health's Amortization of Deferred Charges plummeted by 49195.4% in 2021, and later surged by 11148.04% in 2022.
  • Beauty Health's Amortization of Deferred Charges (Quarter) stood at -$9.2 million in 2021, then skyrocketed by 111.48% to $1.1 million in 2022, then changed by 0.0% to $1.1 million in 2023, then decreased by 16.56% to $882000.0 in 2024, then grew by 22.9% to $1.1 million in 2025.
  • Its Amortization of Deferred Charges was $1.1 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.